Published in Am J Hematol on May 01, 2005
Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. Pediatr Blood Cancer (2009) 2.66
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. N Engl J Med (2016) 2.62
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study. Sex Transm Infect (2012) 1.48
Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep (2013) 1.48
Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Anesth Analg (2014) 1.46
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA (2011) 1.38
Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage (2010) 1.09
Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol (2010) 1.01
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use. Blood (2015) 0.96
Patterns of opioid use in sickle cell disease. Am J Hematol (2016) 0.95
Factors associated with hospital readmission in sickle cell disease. BMC Blood Disord (2009) 0.91
Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS), a focus group and decision support tool development project. Acad Emerg Med (2010) 0.90
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease. Haematologica (2010) 0.90
Neurobiological mechanisms of pain in sickle cell disease. Hematology Am Soc Hematol Educ Program (2010) 0.89
Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis. Clin J Pain (2014) 0.88
Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks. Health Qual Life Outcomes (2014) 0.87
Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy. Hematol Rep (2010) 0.84
Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease. Pediatr Blood Cancer (2013) 0.82
Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study. J Pain Manag (2008) 0.80
Outcomes of acute chest syndrome in adult patients with sickle cell disease: predictors of mortality. PLoS One (2014) 0.80
Does cold hypersensitivity increase with age in sickle cell disease? Pain (2014) 0.79
Comparative Analysis of Pain Behaviours in Humanized Mouse Models of Sickle Cell Anemia. PLoS One (2016) 0.79
Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice. Eur J Pharmacol (2015) 0.79
Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis. Transfusion (2015) 0.78
Application of a proactive risk analysis to emergency department sickle cell care. West J Emerg Med (2014) 0.77
Updated Mechanisms of Sickle Cell Disease-Associated Chronic pain. Transl Perioper Pain Med (2015) 0.76
An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine. OMICS (2016) 0.75
Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients. EBioMedicine (2016) 0.75
Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease. Pain Pract (2015) 0.75
IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease. Pharmacogenomics (2016) 0.75
Cognitive Testing of an Electronic Version of the Faces Pain Scale-Revised with Pediatric and Adolescent Sickle Cell Patients. Patient (2016) 0.75
Randomized trial of hypnosis as a pain and symptom management strategy in adults with sickle cell disease. Integr Med Insights (2014) 0.75
Cardiothoracic surgeon management of postoperative cardiac critical care. Arch Surg (2011) 1.44